Provide feedback on RPRA’s proposed 2021 Registry fees for Blue Box and Hazardous and Special Products
Government releases final Hazardous and Special Products Regulation
Various Publications Under the Chemicals Management Plan
Health Canada Updates the Acne Therapy Monograph
REP Guidance Documents – May 2021 Updates
Updates from The Canadian Stewardship Alliance
CMP Publications Plan for July to September 2021
Stakeholder Consultation – Modernizing Health Canada’s Clinical Trials Framework
Extension to provide confirmatory information on risk assessments for nitrosamine impurities
Annual Drug Notification Packages – 2021
